Tag Archives: drug litigation

A jury has ordered the maker of the popular arthritis drug Humira to pay $2.24 million for not warning doctors about a life-threatening side effect. Delores Tietz, of Manda, N.D., was prescribed Humira for rheumatoid arthritis in October 2009 and took it for almost seven months before feeling flu-like symptoms including chest pains and fever. Her symptoms were not treated for weeks until doctors finally diagnosed her illness as histoplasmosis, a severe fungal infection that can be fatal if untreated. …

A patient who was given a shot of a contrast dye that left him unable to move won a $5 million verdict against GE Healthcare, the maker of the dye. Paul Decker, a retired Ohio man suffering from kidney disease, was given a single dose of Omniscan, a contrast agent administered before body scans like MRIs to help technicians and doctors read the scans more clearly. Decker developed a condition called nephrogenic systemic fibrosis after the 2005 scan. NSF is …

A jury has awarded $63 million to the family of a 7-year-old girl who lost her eyesight and nearly died after taking Children’s Motrin. The popular drug can cause a rare disease known as toxic epidermal necrolysis, or “TEN,” that eats away a person’s skin. “It’s like having your skin burned off of you. Imagine your worst sunburn times 1,000. It’s an absolutely devastating condition,” said the family’s attorneys, Bradley M. Henry, of the law firm Meehan, Boyle, Black & …

The manufacturer of the antipsychotic drug Risperdal owes hundreds of millions of dollars to various states for improperly marketing the drug and encouraging doctors to prescribe it for ailments it was not approved for. The drug is also the subject of personal injury lawsuits for, among other side effects, causing adolescent boys to grow breasts. Risperdal, manufactured by Johnson & Johnson subsidiary Janssen Pharmaceuticals Inc., came on the market in 1994. It was designed and approved to treat people with …

  Actos, a popular diabetes drug, has been shown to more than double the risk of bladder cancer in patients taking the medication.         Mobile users click here to view the video.         Lawyers.com Supervising Producer John McCarthy interviews attorney Hunter Shkolnik, an expert on Actos litigation. He describes Actos as a “blockbuster” drug: It has netted its manufacturer tens of billions of dollars and is one of the 10 most-prescribed drugs in the …